Bbia Hits Limit-Up as KOSDAQ Falls 5.71%: Why Nov 20's Gainers Rose
KOSDAQ fell 5.71%, yet Bbia closed at the daily limit with only a quarterly report on file. HLB Life Science had a merger filing, and Hana Aero went from +98% to +6% on its debut.

This is a record of confirmed facts, not a stock recommendation. Figures as of the Nov 20, 2026 close, compiled 16:31 KST.

Selection criteria: two stocks that closed up 10% or more (one at the 30% daily limit) plus one stock that listed today, three in all. The reason is confirmed by a filing for one, and by news reports only for two.
Seoul — KOSPI fell 5.21% to 4,869.96 and KOSDAQ (the tech- and small-cap-heavy market) fell 5.71% to 645.68, yet Bbia (451250) closed at the 30% daily limit, up 29.95%. The company filed nothing to explain it. Only reports that cosmetics stocks were rising on hopes of eased China restrictions on Korean content exist. HLB Life Science (067630, +15.97%) did have a merger filing, and Hana Aero (271160) rose as much as 98% on its first trading day before closing up 6.14%.
At a glance
| Stock | Why it rose | Nature | Evidence | Heat | What to check next |
|---|---|---|---|---|---|
| Bbia (+29.95%) | Cosmetics stocks rose on hopes of easing China restrictions; no report names Bbia directly | Sentiment | Reports only (sector) | 1/4, caution | Any company filing on China, next-day limit-up order balance |
| HLB Life Science (+15.97%) | Renewed merger push with HLB (merger decision filed Nov 19) | Substantive, one-off | Filing confirmed | 1/4, caution | Merger ratio, shareholder meeting, buyback-claim size |
| Hana Aero (+6.14%) | Listing-day sentiment; intraday high of 11,300 won | Sentiment | Reports only | n/a (first day) | Lock-up expiry for institutions, day-two trading value |
Bbia: a limit-up on China-easing hopes, with no company filing

Bbia rose 29.95% to close at 7,810 won. It closed at the limit with zero sell orders and 101,808 shares of buy orders outstanding. On DART (Korea's official disclosure system), the only filing in the past seven days (Nov 13–20) is a quarterly report dated Nov 13. No article names Bbia. Edaily (Nov 19) reported that cosmetics stocks were jumping on hopes the "hanhanryeong" (restrictions on Korean content) would be lifted, and Chosun Biz (Nov 20) said cosmetics stocks were surging on improving Korea-China relations. Bbia may have ridden that wave, but nothing confirms it. Edaily also noted analysts' view that the actual earnings benefit may be limited because dependence on China is lower than before.
Bbia is up 27.4% over five sessions from its Nov 13 close of 6,130 won. It had already gained 6.21% on Nov 19, when foreign investors net sold 39,260 shares and individuals bought the same amount. Trading value was 5.7 billion won.
On the overheating check, one of four signals is lit. Volume was 30.1 times the 20-day average, the price is 22.3% above its 20-day average, and RSI is 66.6. It sits at 45% of its 52-week range, 25.3% below the 52-week high and 0.9% above the 200-day line. It passed all five fundamentals tests, with revenue growth of 25.2%. The single filing is a quarterly report, so we rate it neutral.
To judge whether this lasts, watch whether Bbia discloses any China-related plan or contract. If the move is purely sector sentiment, the test is whether limit-up buy orders and trading value hold the next day.
HLB Life Science: renewed merger push with HLB

HLB Life Science rose 15.97% to 2,650 won. DART shows a merger-decision report filed Nov 19, and the same day KOSDAQ's market division posted a trading halt notice tied to the merger. News Works headlined it "pushing a merger by absorption with HLB," and Bio Times wrote that a 200 billion won buyback claim "will decide the outcome." It is a renewed push at a merger. The stock was up 23.41% at 1:30 pm but closed at 15.97%.
Foreign investors net bought about 107,000 shares from Nov 13 to Nov 19, including 96,816 on Nov 19 alone. Even so, the stock is 31.3% below its Oct 19 close of 3,860 won, 48.5% below its 52-week high and 20.9% below its 200-day line. The Fact reported that HLB's liver cancer drug has failed three times over manufacturing-facility issues and that no FDA inspection notice has arrived. The merger filing is neutral in nature, since the terms are unknown from the headline. There were also two exchange-price adjustment filings, on Nov 13 (15th) and Nov 20 (16th). We have only their titles.
One of four overheating signals is lit: volume 27.2 times the 20-day average, RSI 24.2, and 5.7% below the 20-day average. Closing orders were 32,233 shares to buy against 16,048 to sell.
To see how firm this is, watch for the merger ratio, shareholder meeting schedule and the size of buyback claims in later filings. Also watch whether more exchange-price adjustments follow, since they bear on share-count dilution.
Hana Aero: up as much as 98% on debut, closing up 6%

Hana Aero gained 6.14% to close at 6,050 won on its first KOSDAQ trading day. The confirmed reason is the listing itself and the sentiment around it. No company filing appeared on DART today. Jaekyung Ilbo reported that it "surged 98% intraday before narrowing to 6%," and Vegan News put the intraday high at 11,300 won. The close is about 46% below that high (EBN). At 1:30 pm it was up 44.21% at 8,220 won. Trading value was 469.2 billion won, and closing orders were 44,538 shares to buy against 25,692 to sell.
On ownership, Data Investment and Digital Today reported that the largest shareholder, Yuil Technology Investment, newly holds 46.27% of the shares. Financial Post ran a headline mentioning "expanded Bell supply next year," but it is not a contract the company confirmed in a filing. Because it is a listing day, there is no prior price for five- or 20-day moves or overheating checks.
To gauge what happens next, check when institutional lock-ups expire and how many shares then reach the market. Also see whether day-two trading value holds up, and whether the open stays above the 6,050 won close, given the wide gap between the intraday high and the close.
FAQ
Why did they rise? Bbia hit the limit on a day cosmetics stocks rose on hopes of China easing, though no report names it. HLB Life Science had a renewed-merger filing with HLB, and Hana Aero was a listing-day stock.
Which filing backs it? For HLB Life Science, the Nov 19 merger-decision report. Bbia has only a Nov 13 quarterly report, and Hana Aero has no filing in the past seven days.
What's next? Merger ratio and shareholder meeting filings for HLB Life Science, the institutional lock-up expiry for Hana Aero, and any further company filing for Bbia.
What happened to the stocks we covered earlier
Six stocks were rated "reports only" in earlier articles. By the Nov 20 close, Korea Cosmetics rose 1.9%, Studio Dragon 1.0% and Big Wave Robotics 3.4%, while Wemade Max fell 8.6%, Ari Bio Lab 4.0% and Gyeyang Electric 16.7%. Yeseon Tech, which had no confirmed reason, fell 14.0%, and Optonics, a new listing, fell 47.6% from 17,550 won to 9,200 won. KOSDAQ fell 5.71% today, but the stocks with weaker reasons fell the most.
| Stock | Verdict then | Close at article | Nov 20 close | Change |
|---|---|---|---|---|
| Korea Cosmetics | Reports only | 6,460 won | 6,580 won | +1.9% |
| Studio Dragon | Reports only | 30,800 won | 31,100 won | +1.0% |
| Wemade Max | Reports only | 4,235 won | 3,870 won | -8.6% |
| Ari Bio Lab | Reports only | 5,290 won | 5,080 won | -4.0% |
| Big Wave Robotics | Reports only | 17,090 won | 17,670 won | +3.4% |
| Yeseon Tech | No reason found | 1,424 won | 1,225 won | -14.0% |
| Optonics | New listing | 17,550 won | 9,200 won | -47.6% |
| Gyeyang Electric | Reports only | 2,935 won | 2,445 won | -16.7% |
FAQ
Why did Bbia stock go up?
Cosmetics stocks rose on hopes of easing China restrictions; no report names Bbia directly. Evidence: Reports only (sector). What to check next: 1/4, caution.
Why did HLB Life Science stock go up?
Renewed merger push with HLB (merger decision filed Nov 19). Evidence: Filing confirmed. What to check next: 1/4, caution.
Why did Hana Aero stock go up?
Listing-day sentiment; intraday high of 11,300 won. Evidence: Reports only. What to check next: n/a (first day).